diazoxide has been researched along with c-peptide in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Fajans, SS; Floyd, JC | 1 |
| Rotenstein, D; Serbin, S; Welsh, T | 1 |
| Landgraf, R; Spelsberg, F; Wirsching, R | 1 |
| Cerasi, E; Glaser, B; Higazi, AA; Landau, H; Leibowitz, G; Salameh, M | 1 |
| Alberti, KG; Kendall-Taylor, P; Trajano, LR; Walker, M | 1 |
| Berne, C; Björk, E; Kämpe, O; Karlsson, FA; Oskarsson, P; Wibell, L | 1 |
| Berne, C; Björk, E; Karlsson, FA | 1 |
| Hansen, JB; Hornum, L; Mandrup-Poulsen, T; Markholst, H; Rasmussen, SB; Sørensen, TS | 1 |
| Abbink, EJ; Jansen van Rosendaal, A; Lutterman, JA; Pickkers, P; Russel, FG; Smits, P; Tack, CJ | 1 |
| Adamson, U; Björklund, A; Grill, V; Guldstrand, M; Lins, PE | 1 |
| Ersoy, F; Gonc, EN; Turul, T; Yordam, N | 1 |
| Aynsley-Green, A; Hussain, K; Otonkoski, T; Thornton, PS | 1 |
| Aman, J; Bengtsson, M; Berglund, L; Berne, C; Björk, E; Forsander, G; Johansson, C; Karlsson, FA; Lindgren, F; Ludvigsson, J; Ortqvist, E; Persson, B; Wallensteen, M | 1 |
| Baumann, U; Green, A; Kelly, DA; McKiernan, PJ; Preece, MA | 1 |
| Burcus, N; Jap, TS; Lee, CH; Lin, HD; Pittenger, G; Tang, KT; Tseng, HS; Vinik, A; Won, JG; Yang, AH | 1 |
| Astrup, A; Due, A; Eriksen, G; Flint, A; Hansen, JB; Møller, B; Raben, A | 1 |
| Arbeláez, AM; Cryer, PE; Ramanathan, RP | 1 |
| Reid, W; Swaminathan, K; Young, R | 1 |
| Drain, P; Luppi, P | 1 |
| Abdel-Wahab, YH; Flatt, PR; McKillop, AM; Ng, MT | 1 |
| Balamurugan, K; Bhavatharini, A; Bodhini, D; Das, AK; Jahnavi, S; Jain, V; Kanthimathi, S; Kaur, T; Khadgawat, R; Mohan, V; Poovazhagi, V; Radha, V; Sikdar, M; Yadav, J | 1 |
| Aso, Y; Hiraishi, H; Kojima, M; Shimizu, M; Suzuki, K; Tsuchida, K | 1 |
| Kim, MS; Kong, YH; Lee, DY | 1 |
| Basak, D; Chatterjee, S; Flanagan, SE; Hussain, K; Khawash, P | 1 |
| Berberabe, A; Pagsisihan, D; Palugod-Lopez, EG; Sandoval, MA | 1 |
| Felechosa, MD; García Moreira, V; Veiguela Blanco, B | 1 |
| Burling, K; Cardoso, L; Church, D; Clarke, C; Cohen, M; Freudenthal, B; Führer, D; Gribble, FM; Halsall, D; Harris, J; Jones, TH; Karra, E; Kay, RG; Khoo, B; Moeller, LC; Moorthy, M; Munir, A; Reimann, F; Semple, RK; Williams, AJK; Williams, CL | 1 |
| Blankenstein, O; Bollow, E; Datz, N; Fröhlich-Reiterer, E; Grulich-Henn, J; Holl, RW; Meissner, T; Menzel, U; Mohnike, K; Warncke, K; Welters, A | 1 |
| Davidov, AS; Elkon-Tamir, E; Eyal, O; Haham, A; Lebenthal, Y; Mandel, D; Oren, A; Shefer, G; Weintrob, N | 1 |
3 review(s) available for diazoxide and c-peptide
| Article | Year |
|---|---|
Diagnosis and medical management of insulinomas.
Topics: Adenoma, Islet Cell; Angiography; Antineoplastic Agents; Benzothiadiazines; Blood Glucose; C-Peptide; Catheterization; Diagnosis, Differential; Diazoxide; Epinephrine; Hypoglycemia; Pancreas; Pancreatic Neoplasms; Portal Vein; Proinsulin; Somatostatin; Splenic Vein; Tomography, X-Ray Computed | 1979 |
[Islet cell cancer with organic hyperinsulinism. Clinical aspects, diagnosis and therapy].
Topics: Adenoma; Adenoma, Islet Cell; C-Peptide; Diagnosis, Differential; Diazoxide; Female; Glucagon; Humans; Hyperinsulinism; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Prognosis; Proinsulin; Streptozocin | 1982 |
Autoimmune hypoglycemia due to anti-insulin antibodies.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoimmune Diseases; C-Peptide; Dexamethasone; Diazoxide; Diet, Diabetic; Female; Glucose; Glucose Intolerance; Humans; Hyperinsulinism; Hypoglycemia; Immunosuppressive Agents; Insulin; Liver Neoplasms; Polyethylene Glycols; Proinsulin; Sigmoid Neoplasms | 2018 |
7 trial(s) available for diazoxide and c-peptide
| Article | Year |
|---|---|
Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
Topics: Adult; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Diazoxide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon; Glutamate Decarboxylase; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Placebos; Time Factors | 1996 |
Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.
Topics: Adult; Antihypertensive Agents; Blood Glucose; C-Peptide; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diazoxide; Female; Food; Glucagon; Glycated Hemoglobin; Hormones; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Octreotide; Postprandial Period | 1998 |
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide; Dipyridamole; Double-Blind Method; Female; Forearm; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Vasodilation | 2002 |
Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes.
Topics: Antihypertensive Agents; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diazoxide; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Obesity; Proinsulin; Regression Analysis; Triglycerides | 2002 |
Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.
Topics: Adolescent; C-Peptide; Child; Diabetes Mellitus, Type 1; Diazoxide; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Vasodilator Agents | 2004 |
No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
Topics: Adult; Blood Glucose; C-Peptide; Counseling; Diazoxide; Diet, Reducing; Double-Blind Method; Energy Intake; Female; Humans; Hyperinsulinism; Insulin; Insulin Antagonists; Insulin Secretion; Male; Obesity; Patient Dropouts; Placebos; Vasodilator Agents; Weight Loss | 2007 |
Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
Topics: Adult; Blood Glucose; C-Peptide; Diazoxide; Female; Glucagon; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; KATP Channels; Male; Sulfonylurea Compounds; Young Adult | 2011 |
19 other study(ies) available for diazoxide and c-peptide
| Article | Year |
|---|---|
Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide.
Topics: Blood Glucose; C-Peptide; Cyproheptadine; Diazoxide; Drug Combinations; Female; Humans; Hyperinsulinism; Infant; Insulin; Palliative Care | 1992 |
Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up.
Topics: Adolescent; C-Peptide; Child; Diabetes Mellitus; Diazoxide; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Islets of Langerhans; Male; Octreotide; Pancreatectomy; Pancreatic Diseases; Prospective Studies; Time Factors | 1995 |
Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Topics: Aged; C-Peptide; Diazoxide; Female; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulinoma; Pancreatic Neoplasms; Propranolol; Recurrence; Thyrotoxicosis | 1994 |
Functional rest through intensive treatment with insulin and potassium channel openers preserves residual beta-cell function and mass in acutely diabetic BB rats.
Topics: Animals; Arginine; Blood Glucose; C-Peptide; Cells, Cultured; Diabetes Mellitus, Type 1; Diazoxide; Glucagon; Glucose Tolerance Test; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Potassium Channels; Rats; Rats, Inbred BB; Rats, Inbred WF | 2000 |
Trimethoprim-sulfamethoxazole induced prolonged hypoglycemia in an infant with MHC class II deficiency: diazoxide as a treatment option.
Topics: Blood Glucose; C-Peptide; Diazoxide; Drug Administration Schedule; Female; Gene Expression; Genes, MHC Class II; Glucose; Histocompatibility Antigens Class II; Hospitalization; Humans; Hyperinsulinism; Hypoglycemia; Immunologic Deficiency Syndromes; Infant; Infusions, Intravenous; Pneumonia; Seizures; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Severe transient neonatal hyperinsulinism associated with hyperlactataemia in non-asphyxiated infants.
Topics: Acidosis; Age of Onset; Blood Glucose; C-Peptide; Chlorothiazide; Diazoxide; Diuretics; Fasting; Fatty Acids, Nonesterified; Female; Fibroblasts; Humans; Hyperinsulinism; Hypoglycemia; Infant, Newborn; Ketone Bodies; Lactates; Male; Skin | 2004 |
Hyperinsulinism in tyrosinaemia type I.
Topics: Blood Glucose; C-Peptide; Chlorothiazide; Diazoxide; Diuretics; Humans; Hyperinsulinism; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Insulin; Liver Diseases; Pancreatic Diseases; Sodium Chloride Symporter Inhibitors; Tyrosinemias | 2005 |
Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS).
Topics: Adult; Aged; Amyloid; Antigens, Neoplasm; Biomarkers; Biomarkers, Tumor; C-Peptide; Cell Proliferation; Diazoxide; Fasting; Female; Homeodomain Proteins; Humans; Hyperinsulinism; Hypoglycemia; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Lectins, C-Type; Male; Middle Aged; Nesidioblastosis; Pancreatectomy; Pancreatitis-Associated Proteins; Postprandial Period; Proinsulin; Receptors, Calcium-Sensing; Syndrome; Trans-Activators | 2006 |
The diagnosis was in her birthday party!
Topics: Aged, 80 and over; Blood Glucose; C-Peptide; Confusion; Diazoxide; Epilepsy, Tonic-Clonic; Female; Humans; Hypoglycemia; Insulin; Insulinoma; Pancreatic Neoplasms; Vasodilator Agents; Weight Gain | 2012 |
Autocrine C-peptide mechanism underlying INS1 beta cell adaptation to oxidative stress.
Topics: Adaptation, Physiological; Animals; Apoptosis; Autocrine Communication; C-Peptide; Cell Line, Tumor; Diazoxide; Disease Models, Animal; Glucose; Glyburide; Hydrogen Peroxide; Hypoglycemic Agents; Insulin-Secreting Cells; Insulinoma; Oxidative Stress; Pancreatic Neoplasms; Potassium Chloride; Rats; Reactive Oxygen Species | 2014 |
Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.
Topics: Animals; C-Peptide; Cell Line; Diazoxide; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Rats; Tolbutamide | 2014 |
Novel ABCC8 (SUR1) gene mutations in Asian Indian children with congenital hyperinsulinemic hypoglycemia.
Topics: Asian People; Base Sequence; C-Peptide; Congenital Hyperinsulinism; Diazoxide; Humans; India; Insulin; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Sulfonylurea Receptors | 2014 |
Insulinoma in a patient with chronic renal failure due to type 2 diabetes mellitus treated effectively with diazoxide.
Topics: Antihypertensive Agents; Biomarkers, Tumor; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diazoxide; Humans; Hypoglycemia; Insulin; Insulinoma; Kidney Failure, Chronic; Male; Middle Aged; Pancreatic Neoplasms; Renal Dialysis; Treatment Outcome; Vasodilator Agents | 2015 |
A Case of Subclinical Hypothyroidism with Lingual and Right Pretracheal Ectopic Thyroid.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Choristoma; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Diuretics; Drug Resistance; Female; Humans; Infant, Newborn; Insulin; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors; Thyroid Gland; Tongue Diseases | 2015 |
Nifedipine in Congenital Hyperinsulinism - A Case Report.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Diuretics; Drug Resistance; Female; Humans; Infant, Newborn; Insulin; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors | 2015 |
A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.
Topics: Biopsy; Blood Glucose; C-Peptide; Carcinoma, Neuroendocrine; Diazoxide; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Secretion; Insulinoma; Liver Neoplasms; Male; Middle Aged; Octreotide; Pancreas; Pancreatectomy; Pancreatic Neoplasms | 2016 |
Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome.
Topics: Adult; Aged; Autoimmune Diseases; Biomarkers; Blood Glucose; C-Peptide; Chromatography, Gel; Congenital Hyperinsulinism; Diazoxide; Female; Humans; Immunosuppressive Agents; Insulin; Insulin Antibodies; Insulin Resistance; Male; Middle Aged; Syndrome | 2018 |
Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Child, Preschool; Congenital Hyperinsulinism; Diabetes Mellitus, Type 1; Diazoxide; Female; Humans; Hypoglycemia; Insulin; Male; Octreotide; Pancreas; Pancreatectomy | 2018 |
Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Diazoxide; Female; Gestational Age; Humans; Hyperinsulinism; Hypoglycemia; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Retrospective Studies | 2020 |